IL-1 and TNF induction of matrix metalloproteinase-3 by c-Jun N-terminal kinase in trabecular meshwork

被引:38
|
作者
Hosseini, M
Rose, AY
Song, KL
Bohan, C
Alexander, JP
Kelley, MJ
Acott, TS
机构
[1] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97239 USA
[2] Triple Point Biol, Forest Grove, OR USA
关键词
D O I
10.1167/iovs.05-0451
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. The cytokines TNF and IL-1 mediate the MMP-3 increase that occurs in response to trabecular meshwork (TM) treatment by laser trabeculoplasty. This MMP-3 increase appears to play a key role in the efficacy of this treatment for open-angle glaucoma. Protein kinase C mu and the Erk mitogen-activated protein (MAP) kinases are essential signaling components in transducing MMP-3 increases produced by treatment of TM cells with these cytokines. Here, the involvement of the JNK-MAP kinase pathway in this process was evaluated. METHODS. Porcine TM cells were treated with TNF alpha, IL-1 alpha, or IL-1 beta. Changes in MMP-3 and MMP-9 protein levels in the media were then determined by Western immunoblot. The effect of JNK inhibitor 2 was evaluated. Changes in the level of phosphorylation of JNK, c-Jun, ATF-2, MKK4, and MKK7 were also determined at various times after TNF alpha or IL-1 alpha treatment. A 2.3-kb MMP-3 promoter fragment was cloned into a secreted alkaline phosphatase reporter vector. This reporter construct was cotransfected into TM cells with a mammalian expression vector containing a dominant-negative mutant of JNK. The involvement of JNK activity in the TNF alpha and IL-1 alpha induction of MMP-3 expression was then evaluated. RESULTS. TNF alpha, IL-1 alpha, and IL-10 increase media MMP-3 and MMP-9 protein levels, and JNK inhibitor 2 blocks these increases. JNK1/2, MKK4, c-Jun, and ATF-2 phosphorylation levels increase in response to TNF alpha and IL-1 alpha treatment. JNK inhibitor 2 pretreatment blocks these c-Jun and ATF-2 phosphorylation increases. Dominant-negative JNK dramatically reduces the MMP-3 promoter-driven reporter activity induced by these cytokines. CONCLUSIONS. JNK activity is necessary for the induction of MMP-3 and MMP-9 by TNF alpha, IL-1 alpha, or IL-1 beta in TM cells. Phosphorylation of components of the JNK signaling pathway and of the transcription factors c-Jun and ATF-2 support a role for this pathway in the induction of MMP-3 and MMP-9 in the TM in response to these cytokines. Thus, at least three separate signal transduction pathways are necessary in this signaling event in TM cells.
引用
收藏
页码:1469 / 1476
页数:8
相关论文
共 50 条
  • [41] The Roles of c-Jun N-Terminal Kinase (JNK) in Infectious Diseases
    Chen, Jing
    Ye, Chao
    Wan, Chao
    Li, Gang
    Peng, Lianci
    Peng, Yuanyi
    Fang, Rendong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (17)
  • [42] Activated c-Jun N-terminal kinase is required for axon formation
    Oliva, Anthony A., Jr.
    Atkins, Coleen M.
    Copenagle, Lily
    Banker, Gary A.
    JOURNAL OF NEUROSCIENCE, 2006, 26 (37): : 9462 - 9470
  • [43] Prolactin stimulates activation of c-jun N-terminal kinase (JNK)
    Schwertfeger, KL
    Hunter, S
    Heasley, LE
    Levresse, V
    Leon, RP
    DeGregori, J
    Anderson, SM
    MOLECULAR ENDOCRINOLOGY, 2000, 14 (10) : 1592 - 1602
  • [44] Interaction of c-jun N-terminal kinase JNK with inhibitory peptides
    Friebe, A.
    Hanke, S.
    Heil, B.
    Kruse, C.
    Spira, F.
    Hennemann, H.
    JOURNAL OF PEPTIDE SCIENCE, 2006, 12 : 153 - 153
  • [45] Evidence of Presynaptic Localization and Function of the c-Jun N-Terminal Kinase
    Biggi, Silvia
    Buccarello, Lucia
    Sclip, Alessandra
    Lippiello, Pellegrino
    Tonna, Noemi
    Rumio, Cristiano
    Di Marino, Daniele
    Miniaci, Maria Concetta
    Borsello, Tiziana
    NEURAL PLASTICITY, 2017, 2017
  • [46] Small Molecule JNK (c-Jun N-Terminal Kinase) Inhibitors
    Siddiqui, M. Arshad
    Reddy, Panduranga A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (08) : 3005 - 3012
  • [47] Role of c-Jun N-terminal Kinase in the Regulation of Vascular Tone
    Zhou, Ming-Sheng
    Schulman, Ivonne Hernandez
    Chadipiralla, Kiranmai
    Raij, Leopoldo
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2010, 15 (01) : 78 - 83
  • [48] Role of c-JUN N-terminal kinase in glial inflammatory response
    Bhat, NR
    Pawate, S
    Shen, Q
    Fan, F
    JOURNAL OF NEUROCHEMISTRY, 2003, 85 : 13 - 13
  • [49] c-Jun N-Terminal Kinase Phosphorylation Is a Biomarker of Plitidepsin Activity
    Munoz-Alonso, Maria J.
    Alvarez, Enrique
    Jose Guillen-Navarro, Maria
    Pollan, Marina
    Aviles, Pablo
    Galmarini, Carlos M.
    Munoz, Alberto
    MARINE DRUGS, 2013, 11 (05): : 1677 - 1692
  • [50] MEASURING THE CONSTITUTIVE ACTIVATION OF C-JUN N-TERMINAL KINASE ISOFORMS
    Nitta, Ryan T.
    Badal, Shawn S.
    Wong, Albert J.
    METHODS IN ENZYMOLOGY, VOLUME 484: CONSTITUTIVE ACTIVITY IN RECEPTORS AND OTHER PROTEINS, PART A, 2010, 484 : 531 - 548